EVHEvolent Health, Inc.

NYSE evolenthealth.com


$ 24.89 $ -0.11 (-0.44 %)    

Friday, 10-May-2024 10:42:37 EDT
QQQ $ 441.84 $ -1.12 (-0.25 %)
DIA $ 395.37 $ 0.11 (0.03 %)
SPY $ 521.09 $ -0.45 (-0.09 %)
TLT $ 90.11 $ -0.20 (-0.22 %)
GLD $ 218.73 $ -1.05 (-0.48 %)
$ 26.96
$ 25.00
$ 24.86 x 100
$ 25.10 x 100
$ 24.65 - $ 26.37
$ 23.33 - $ 35.83
1,637,292
na
3B
$ 1.25
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-09-2024 03-31-2024 10-Q
2 02-23-2024 12-31-2023 10-K
3 11-02-2023 09-30-2023 10-Q
4 08-02-2023 06-30-2023 10-Q
5 05-04-2023 03-31-2023 10-Q
6 02-24-2023 12-31-2022 10-K
7 11-03-2022 09-30-2022 10-Q
8 08-03-2022 06-30-2022 10-Q
9 05-04-2022 03-31-2022 10-Q
10 02-23-2022 12-31-2021 10-K
11 11-03-2021 09-30-2021 10-Q
12 08-04-2021 06-30-2021 10-Q
13 05-06-2021 03-31-2021 10-Q
14 02-26-2021 12-31-2020 10-K
15 11-06-2020 09-30-2020 10-Q
16 08-10-2020 06-30-2020 10-Q
17 05-28-2020 03-31-2020 10-Q
18 03-02-2020 12-31-2019 10-K
19 11-05-2019 09-30-2019 10-Q
20 08-09-2019 06-30-2019 10-Q
21 05-09-2019 03-31-2019 10-Q
22 02-28-2019 12-31-2018 10-K
23 11-08-2018 09-30-2018 10-Q
24 08-09-2018 06-30-2018 10-Q
25 05-10-2018 03-31-2018 10-Q
26 03-01-2018 12-31-2017 10-K
27 11-09-2017 09-30-2017 10-Q
28 08-07-2017 06-30-2017 10-Q
29 05-10-2017 03-31-2017 10-Q
30 03-03-2017 12-31-2016 10-K
31 11-10-2016 09-30-2016 10-Q
32 08-09-2016 06-30-2016 10-Q
33 05-16-2016 03-31-2016 10-Q
34 02-29-2016 12-31-2015 10-K
35 11-06-2015 09-30-2015 10-Q
36 08-07-2015 06-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 evolent-and-careology-form-partnership-to-enhance-cancer-care-in-the-us

Digital cancer care platform Careology and Evolent (NYSE:EVH) to offer an innovative platform to enable cancer navigationEvolen...

 evolent-health-sees-q2-revenue-625m-645m-vs-60664m-est-fy24-revenue-253b-260b-vs-247b-est

Second Quarter 2024 GuidanceFor the three months ended June 30, 2024, revenue is expected to be in the range of approximately $...

 evolent-health-q1-adj-034-beats-024-estimate-sales-63965m-beat-60082m-estimate

Evolent Health (NYSE:EVH) reported quarterly earnings of $0.34 per share which beat the analyst consensus estimate of $0.24 by ...

 citigroup-initiates-coverage-on-evolent-health-with-buy-rating-announces-price-target-of-40

Citigroup analyst Daniel Grosslight initiates coverage on Evolent Health (NYSE:EVH) with a Buy rating and announces Price Ta...

 canaccord-genuity-maintains-buy-on-evolent-health-lowers-price-target-to-44

Canaccord Genuity analyst Richard Close maintains Evolent Health (NYSE:EVH) with a Buy and lowers the price target from $45 ...

 jp-morgan-maintains-overweight-on-evolent-health-lowers-price-target-to-52

JP Morgan analyst Anne Samuel maintains Evolent Health (NYSE:EVH) with a Overweight and lowers the price target from $53 to ...

 oppenheimer-initiates-coverage-on-evolent-health-with-outperform-rating-announces-price-target-of-45

Oppenheimer analyst Jeff Jones initiates coverage on Evolent Health (NYSE:EVH) with a Outperform rating and announces Price ...

 these-analysts-revise-their-forecasts-on-evolent-health-after-upbeat-results

Evolent Health, Inc. (NYSE: EVH) reported better-than-expected fourth-quarter results on Thursday.

 why-mercadolibre-shares-are-trading-lower-by-around-10-here-are-other-stocks-moving-in-fridays-mid-day-session

Shares of MercadoLibre, Inc. (NASDAQ: MELI) fell sharply during Friday’s session after the company reported fourth-quarter fin...

 jmp-securities-maintains-market-outperform-on-evolent-health-raises-price-target-to-38

JMP Securities analyst Constantine Davides maintains Evolent Health (NYSE:EVH) with a Market Outperform and raises the price...

 canaccord-genuity-maintains-buy-on-evolent-health-lowers-price-target-to-45

Canaccord Genuity analyst Richard Close maintains Evolent Health (NYSE:EVH) with a Buy and lowers the price target from $47 ...

 evolent-health-q4-eps-023-beats-015-estimate-sales-55605m-beat-54239m-estimate

Evolent Health (NYSE:EVH) reported quarterly earnings of $0.23 per share which beat the analyst consensus estimate of $0.15 by ...

 evolent-health-q4-sales-55605m-beat-54240m-estimate

Evolent Health (NYSE:EVH) reported quarterly sales of $556.05 million which beat the analyst consensus estimate of $542.40 mill...

 earnings-scheduled-for-february-22-2024

Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is likely to report quarterly earnings at $0.28 per share on reve...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION